CRISPR-Cas9 is a powerful gene editing system that has revolutionized our ability to treat disease and probe the human genome ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

The CRISPR-Cas9 patent landscape remains complex and unsettled. The Federal Circuit’s latest decision in University of California v.

The only gene-editing therapy currently on the market is a CRISPR–Cas9-based treatment for two blood disorders, sickle-cell ...

For years, the CRISPR-Cas9 genome technology has been reshaping ... “The ability to apply CRISPR gene-editing to spider silk is very promising for materials science research – for example ...

Investors interested in the Genomics and Synthetic Biology theme may consider adding these three stocks to their portfolio - ...

The gene editor -- called evoCAST -- goes a long way toward solving a problem that has confounded the development of gene therapies from the field's beginnings: How to add long stretches of DNA to ...

Gene editing, once a theoretical ambition, has matured into a revolutionary frontier in biotechnology. Technologies like CRISPR-Cas9, TALENs, and Zinc Finger Nucleases (ZFNs) have unlocked ...

This is the first gene editor to use a CRISPR-associated transposase to make targeted edits at therapeutically useful levels ...

Explore how CRISPR could become a powerful antiviral tool against HIV, Hepatitis B, HPV, and more, based on emerging research.